Sugammadex Injection, Solution
Product Images NDC 31722-255

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 31722-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sugammadexinjcarton200mg2ml (Sugammadexinjcarton200mg2ml)

Sugammadexinjcarton200mg2ml (Sugammadexinjcarton200mg2ml)
Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use. The carton design features the Camber Pharmaceuticals logo and states the package contains 10 single-dose 2 mL vials. The label includes dosage strength, route of administration, and manufacturer details, including the manufacturing location and distributor information.*
FDA Label Image

Sugammadexinjcarton500mg5ml (Sugammadexinjcarton500mg5ml)

Sugammadexinjcarton500mg5ml (Sugammadexinjcarton500mg5ml)
Carton label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) by Camber Pharmaceuticals, Inc. The label states the product is for intravenous use only and contains 10 single-dose 5 mL vials. The label includes dosage instructions, storage conditions, and manufacturer details, including a barcode and lot information.*
FDA Label Image

Sugammadexinjfigure1 (Sugammadexinjfigure1)

Sugammadexinjfigure1 (Sugammadexinjfigure1)
A plot showing cumulative recovery rate over time (minutes) comparing sugammadex at 2 mg/kg and neostigmine at 0.05 mg/kg. The chart includes median recovery times and quartiles, with sugammadex showing faster recovery rates than neostigmine.*
FDA Label Image

Sugammadexinjfigure2 (Sugammadexinjfigure2)

Sugammadexinjfigure2 (Sugammadexinjfigure2)
A cumulative recovery rate plot comparing Sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time in minutes. The graph illustrates recovery time differences between treatments with median and quartile statistics shown for each drug.*
FDA Label Image

Sugammadexinjstructure1 (Sugammadexinjstructure1)

Sugammadexinjstructure1 (Sugammadexinjstructure1)
Chemical structure of Sugammadex shown as a detailed molecular diagram indicating sodium carboxylate groups and multiple oxygen and sulfur atoms in a cyclic arrangement.*
FDA Label Image

Sugammadexinjstructure2 (Sugammadexinjstructure2)

Sugammadexinjstructure2 (Sugammadexinjstructure2)
Chemical structure of Sugammadex, showing its complex cyclic arrangement with multiple sodium carboxylate groups and hydroxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.